Symphogen Competitors and Similar CompaniesClear all

Epizyme's competitors and similar companies include Chugai Pharmaceutical.
Epizyme
Epizyme
Epizyme is a clinical stage biopharmaceutical company focusing on treatments for blood cancer and tumors.
Chugai Pharmaceutical
Chugai Pharmaceutical
Chugai Pharmaceutical is a pharmaceutical company specializing in the fields of oncology, as well as bone, joint, and renal diseases.
Founding Date
Founding Date
2007
Founding Date
1925
Type
Type
Public
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Locations
Chuo City, JP HQ
Guangzhou Shi, CN
Taizhou, CN
Puteaux, FR
Frankfurt Am Main, DE
Singapore, SG
see more
Employees
Employees
20364% increase
Employees
7,778
Valuation ($)
Valuation ($)
250.8 m
Valuation ($)
78.7 b

Financial

Revenue (est.)
Revenue (est.)
$37.4m (FY, 2021)
Revenue (est.)
¥1.3t (FY, 2025)
Cost of goods
Cost of goods
$10.5m (FY, 2021)
Cost of goods
¥363.7b (FY, 2025)
Net income
Net income
($251.1m) (FY, 2021)
Net income
¥434b (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

Chugai Pharmaceutical
HQ
Chuo City, JP
Employees
7,778

Chugai Pharmaceutical is a pharmaceutical company specializing in the fields of oncology, as well as bone, joint, and renal diseases.

View company